Effect of Neuromuscular Blockade Reversal With Sugammadex on Oxygenation, Pain and Arousal States in the Post Anesthesia Care Unit
Phase of Trial: Phase IV
Latest Information Update: 30 Aug 2016
At a glance
- Drugs Sugammadex (Primary) ; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- Acronyms Neuropa
- 14 Aug 2016 Status changed from recruiting to completed.
- 07 Dec 2015 Planned primary completion date changed from 1 Nov 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov.
- 31 Aug 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Nov 2015, as reported by ClinicalTrials.gov.